|Bid||41.72 x 1000|
|Ask||42.77 x 800|
|Day's range||41.37 - 41.78|
|52-week range||34.74 - 51.18|
|Beta (5Y monthly)||0.43|
|PE ratio (TTM)||28.81|
|Earnings date||05 Feb 2024 - 09 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||47.39|
Key Insights The projected fair value for Qiagen is US$36.75 based on 2 Stage Free Cash Flow to Equity Current share...
Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
QIAGEN’s ForenSeq Kintelligence System recently used by DNA Labs International in the U.S. to solve unidentified remains case in Oregon and 51-year-old criminal investigation in Georgia // ForenSeq Kintelligence enables identification of distant relatives in genealogy databases, helping to resolve previously unsolvable cases and bringing answers to victims and families // DNA Labs International is one of the first labs to offer this new approach to human identificationVenlo, the Netherlands, and